Genmab A/S

Contributing Author

Recent Articles by Genmab A/S

May-21	Genmab to Participate in a Fireside Chat at the 2025 Jefferies Global Health Care Conference GMAB GlobeNewswire
May-20	Capital Increase in Genmab as a Result of Employee Warrant Exercise GMAB GlobeNewswire
May-19	Transactions in Connection with Share Buy-back Program GMAB GlobeNewswire
May-14	Genmab to Present New and Updated Results from its Robust Epcoritamab (EPKINLY) Development Program at the 2025 European Hematology Association (EHA) Congress GMAB GlobeNewswire
May-12	Transactions in Connection with Share Buy-back Program GMAB GlobeNewswire
May-08	Genmab Announces Financial Results for the First Quarter of 2024 GMAB GlobeNewswire
May-05	Transactions in Connection with Share Buy-back Program GMAB GlobeNewswire
May-01	Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL) GMAB GlobeNewswire